In Vitro Diagnostics: World Market Outlook 2011-2021 - Can This Market Achieve Growth?
NEW YORK, Aug. 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
In Vitro Diagnostics: World Market Outlook 2011-2021 - Can this market achieve growth?
http://www.reportlinker.com/p0578540/In-Vitro-Diagnostics-World-Market-Outlook-2011-2021---Can-this-market-achieve-growth.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
How will the in vitro diagnostics (IVD) market develop this decade? Our report shows you potential revenues to 2021, discussing opportunities and prospects. Through our research and analysis we aim to save you time and help in your decisions.
Our new study shows you potential revenues to 2021 for in vitro diagnostics at total world, submarket and national levels. What technologies and applications will expand that market? What effects will changes have? You will find predictions and answers.
In our report you will find revenue predictions for clinical chemistry, immunochemistry, haematology, microbiological culture, genetic testing, immunotechnology, point of care testing (POCT) and laboratory testing.
You will find coverage of Roche, Siemens, Abbott Laboratories, Beckman Coulter and Becton, Dickinson and Company. We also discuss Quest Diagnostics, Laboratory Corporation of America and other companies in the medical diagnostics market.
Our study predicts future trends. You will find analyses of IVD applications in diabetes, oncology, infectious diseases, cardiovascular disorders, drug abuse and fertility testing.
We help you to assess the in vitro diagnostics industry and market's strengths, weaknesses, trends and potential revenues to 2021. You will see where those technologies are heading.
Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.
Original analysis with revenues, growth rates, market shares, opinion and discussions
You will find revenue forecasts, growth rates, market shares, a SWOT/STEP review, opinions from our survey and discussions of technologies and companies. We provide 98 tables and charts and two research interviews (shown in the accompanying lists).
In Vitro Diagnostics: World Market Outlook 2011-2021 shows you opportunities, challenges and revenue forecasts
Our report gives you the following advantages:
• You will discover revenue forecasts to 2021 for the world in vitro diagnostics market and its main components, seeing where the highest revenue growth will occur
• You will find revenue forecasts to 2021 for IVD technologies, assessing their commercial potential and applications
• You will discover revenue forecasts to 2021 for leading national markets (US, Japan, Germany, France, Spain, UK, Italy, China and India), seeing growth trends
• You will assess leading companies in IVD, discovering their activities and outlooks
• You will investigate competition and opportunities influencing the IVD industry and market from 2011 onwards
• You will see what will stimulate and restrain the IVD industry and market from 2011
• You will identify diagnostic needs and commercial opportunities, including those for personalised medicine
• You will examine emerging medical diagnostic technologies, including theranostics, seeing opportunities and revenue potential
• You will analyse opportunities and challenges for established companies and those seeking to enter the IVD and personalised medicine market
• You will view opinions from our industry survey, receiving full interview transcripts.
That mix of quantitative and qualitative analysis sets our report apart. We tackle crucial questions in the in vitro diagnostics industry and market, aiming to save you time and effort.
Order our report now to gain industry and market analysis for medical diagnostic tests
Our report is for everybody interested in market analysis, product development, sales and marketing for diagnostic tests and devices. You will find predictions and answers. Don't miss out – please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
NB: All visiongain reports are password locked so please let us know what licence is most suitable for your business needs
Table of Contents
1. Executive Summary
1.1 Overview of the In Vitro Diagnostics World Market, 2011-2021
1.2 The Scope of this Report
1.3 Chapter Outlines
1.4 Research and Analysis Methods
2. Introduction to the In Vitro Diagnostics Industry
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying IVD: EDMA Classification
2.2.1 Clinical Chemistry
2.2.2 Immunochemistry
2.2.3 Haematology
2.2.4 Microbiology
2.2.5 Genetic Testing
2.3 Classifying IVD: Disease Areas
2.4 Regulatory Issues in the IVD Market
2.4.1 FDA Classifications
2.4.2 Regulation of IVD Tests
2.5 Types of IVD Tests
2.6 Personalised Medicine: Pharmacogenomics, Pharmacogenetics, Theranostics and Proteomics
2.6.1 Pharmacogenomics
2.6.2 Proteonomics
2.7 Sensitivity and Specificity
3. The Global In Vitro Diagnostics Market, 2011-2021
3.1 The Global IVD Market in 2009
3.2 Global IVD Market Forecast, 2011-2021
3.3 Global IVD Market Forecasts by EDMA Category, 2011-2021
3.3.1 Clinical Chemistry Market Forecast, 2011-2021
3.3.2 Immunochemistry Market Forecast, 2011-2021
3.3.3 Haematology Market Forecast, 2011-2021
3.3.4 Microbiology (Culture) Market Forecast, 2011-2021
3.3.5 Immunotechnology for Infectious Diseases Market Forecast, 2011-2021
3.3.6 Genetic Testing Market Forecast, 2011-2021
3.3.7 Cytogenetic Tests: FISH (Fluorescence In-Situ Hybridisation)
3.3.7.1 What is FISH?
3.3.7.2 Cytogenetics and FISH Will Drive Growth in the Genetic Testing Market
3.4 Point-of-Care Testing Market Forecast, 2011-2021
3.5 Laboratory Testing Market Forecast, 2011-2021
4. In Vitro Diagnostics: Leading National Markets, 2011-2021
4.1 Leading National Markets for IVD Tests in 2010
4.2 The US IVD Market: Forecast and Outlook, 2011-2021
4.3 The Japanese IVD Market: Forecast and Outlook, 2011-2021
4.4 Leading European IVD Markets: Forecasts and Outlook, 2011-2021
4.4.1 The German IVD Market, 2011-2021
4.4.2 The French IVD Market, 2011-2021
4.4.3 The Italian IVD Market, 2011-2021
4.4.4 The Spanish IVD Market, 2011-2021
4.4.5 The UK IVD Market, 2011-2021
4.5 Top 5 EU Markets, 2011-2021
4.6 Chinese IVD Market: Forecast and Outlook, 2011-2021
4.7 Indian IVD Market: Forecast and Outlook, 2011-2021
4.8 IVD Revenues from Leading Emerging Markets, 2011-2021
4.9 Revenues in the Rest of the World, 2011-2021
4.10 Global IVD Market by Region, 2010
5. Important Therapy Areas for IVD Tests
5.1 Diabetes
5.2 Oncology
5.3 Infectious Disease
5.3.1 Hospital-Acquired Infections
5.3.2 HIV
5.3.3 Tuberculosis
5.3.3.1 Skin Tests
5.3.3.2 Smear Microscopy
5.3.3.3 Microbiological Culture
5.3.3.4 Nucleic Acid Based Testing
5.3.3.5 Immunoassays
5.3.3.6 Phage Assay
5.4 Influenza
5.5 Reproductive Tests
5.6 Drug Abuse
5.6.1 Drugs Commonly Tested For
5.6.2 Types of Samples
5.7 Cardiovascular Disease
5.7.1 Cardiac Markers
5.7.2 Cholesterol Screening
6. Leading Companies in the IVD Industry and Market
6.1 Top 5 IVD Manufacturers
6.2 Roche
6.3 Siemens AG
6.4 Abbott Laboratories
6.5 Beckman Coulter
6.6 Becton Dickinson
6.7 Laboratory Services
6.7.1 Quest Diagnostics
6.7.2 Laboratory Corporation of America
6.7.3 Direct-to-Consumer Genomic Testing Companies
7. Theranostics and Personalised Medicine, 2011-2021
7.1 What is Personalised Medicine?
7.2 Maximising Benefits to Healthcare Stakeholders
7.3 Minimising Harm
7.4 Increasing Compliance
7.5 Streamlining Clinical Trials
7.6 Reviving Failed or Withdrawn Drugs
7.7 Reducing the Costs of Healthcare
7.8 Shifting from Reaction to Prevention
7.9 What is Required for Personalised Medicine to Become Widespread?
7.9.1 The Cost of Genomic Sequencing Must Fall
7.9.2 Large Scale Studies and Databases
7.9.3 A Healthcare IT Infrastructure that Integrates Clinical Data and Other Research
7.9.4 Medical Education
7.9.5 Guaranteed Reimbursements
7.10 Theranostics Forecast, 2011-2021
8. Drivers and Restraints in the IVD Industry and Market, 2011-2021
8.1 SWOT Analysis of the IVD Market Area
8.2 Factors Driving Growth of the IVD Market
8.3 Factors Restraining Growth of the IVD Market
9. Opinions from Our Industry Survey
9.1 Godwin Liu, Marketing Manager, Shenzhen Mindray Bio-Medical Electronics Co.
9.1.1 About Mindray
9.1.2 Unmet Needs in the IVD Market
9.1.3 Growth in the IVD Sector
9.1.4 Challenges Faced by the IVD Market
9.1.5 Market Expansion for IVD Products
9.2 Interview 2: Director of a Diagnostics Company
9.2.1 Most-Promising Therapeutic Areas for IVD
9.2.2 Unmet Medical Needs in IVD
9.2.3 Greatest Obstacles to Market Growth
9.2.4 Prospects for IVD Market Growth in Developing Countries
9.2.5 Prospects for Theranostics
10. Conclusions
10.1 In Vitro Diagnostics are Vital to Clinical Decision Making
10.2 Significant Growth of In Vitro Diagnostics Market from 2010 to 2021
10.3 The Top Five Manufacturers Command the Majority of the IVD Market
10.4 Expansion of the World Market Boosted by Rising Revenues in the Developing Healthcare Markets
10.5 IVD Solutions are the Cornerstone of Personalised Medicine
10.6 Concluding Thoughts on this Expanding Industry and Market
List of Tables
Table 3.1 World Revenues ($bn) and Market Shares (%) by Sub Market, 2010, 2015 and 2021
Table 3.2 Global IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.3 Global IVD Market Forecast by Sub Market ($bn, AGR%, CAGR %), 2009-2021
Table 3.4 World Clinical Chemistry Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.5 Automated Sample Analysers, 2011
Table 3.6 World Immunochemistry Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.7 Immunochemistry IVD Applications, 2010
Table 3.8 World Haematology Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.9 Haematology IVD Applications, 2011
Table 3.10 World Microbiology Culture Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.11 World Infectious Immunology Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.12 World Genetic Testing Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.13 Genetic Testing IVD Applications, 2011
Table 3.14 World POCT Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.15 World Laboratory Testing Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 3.16 Revenues ($bn) for Laboratory Testing and POCT, 2010
Table 3.17 POCT and Laboratory Testing Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.1 Leading National Markets for IVD ($bn, %), 2010, 2015 and 2021
Table 4.2 US IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.3 Japanese IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.4 German IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.5 French IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.6 Italian IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.7 Spanish IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.8 UK IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.9 Top 5 EU IVD Market Forecasts ($bn, AGR%, CAGR %), 2009-2021
Table 4.10 Chinese IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.11 Indian IVD Market Forecast ($bn, AGR%, CAGR %), 2009-2021
Table 4.12 Indian and Chinese IVD Market Forecasts ($bn, AGR%, CAGR %), 2009-2021
Table 4.13 IVD Market Forecast for the Rest of the World ($bn, AGR%, CAGR %), 2009-2021
Table 4.14 Leading National Markets for IVD: Revenue Forecasts ($bn), 2009-2021
Table 4.15 World IVD Market: Regional Revenues ($bn), 2010
Table 5.1 Main Therapy Areas for IVD Testing ($bn, %), 2010
Table 5.2 Diabetes IVD Test Revenues ($bn) and Market Shares (%), 2010
Table 5.3 Oncology IVD Test Revenues ($bn) and Market Shares (%), 2010
Table 5.4 Theranostics for Oncology, 2011
Table 5.5 Infectious Immunology IVD Market Revenues ($bn) and Market Shares (%) by Technology, 2010
Table 5.6 Infectious Immunology Revenues ($bn) and Market Shares (%) by Disease, 2010
Table 5.7 HIV IVD Market Revenues ($bn) and Market Shares (%) by Application, 2010
Table 5.8 TB Diagnostics Revenues ($m) and Market Shares (%), 2010
Table 5.9 Male and Female Fertility Markers, 2011
Table 5.10 Cardiovascular IVD Market Revenues ($bn) and Market Shares (%), 2010
Table 5.11 Cardiac Markers, 2011
Table 5.12 Cardiac IVD Market by Test Type ($bn, %), 2010
Table 6.1 IVD Revenues ($bn) from Leading Companies, 2010
Table 6.2 Roche Diagnostics Revenues ($m), 2010
Table 6.3 Siemens Healthcare Revenues ($m), 2010
Table 6.4 Abbott Laboratories Revenues ($m) for Diagnostics, 2010
Table 6.5 Beckman Coulter Revenues ($m), 2010
Table 6.6 Becton Dickinson Diagnostics Revenues ($m), 2010
Table 6.7 Quest Diagnostics Revenues ($m), 2009
Table 6.8 LabCorp Diagnostics Revenues ($m), 2009
Table 6.9 Conditions Tested for by 23and Me, 2010
Table 7.1 Differences between Traditional and Personalised Medicine
Table 7.2 Average Response Rates to Treatment for Various Diseases, 2010
Table 7.3 Drugs Metabolised by CYP450: 2C19 and 2D6, 2011
Table 7.4 Diagnostics and Theranostics Forecasts ($bn), 2009-2021
Table 8.1 SWOT Analysis of the Global IVD Market, 2011-2021
List of Figures
Figure 3.1 World Market Shares (%) by Sub Market, 2010
Figure 3.2 World Market Shares (%) by Sub Market, 2015
Figure 3.3 World Market Shares (%) by Sub Market, 2021
Figure 3.4 Global IVD Market Forecast ($bn), 2009-2021
Figure 3.5 World Clinical Chemistry Market Forecast ($bn), 2009-2021
Figure 3.6 World Immunochemistry Market Forecast ($bn), 2009-2021
Figure 3.7 World Haematology Market Forecast ($bn), 2009-2021
Figure 3.8 World Microbiology Culture Market Forecast ($bn), 2009-2021
Figure 3.9 World Infectious Immunology Market Forecast ($bn), 2009-2021
Figure 3.10 World Genetic Testing Market Forecast ($bn), 2009-2021
Figure 3.11 World IVD Market Forecast with Sub Markets ($bn), 2009-2021
Figure 3.12 World Point of Care Testing (POCT) Market Forecast ($bn), 2009-2021
Figure 3.13 World Laboratory Testing Market Forecast ($bn), 2009-2021
Figure 3.14 Market Shares (%): Laboratory Testing and POCT, 2010
Figure 4.1 Leading National Market Shares (%) for IVD, 2010
Figure 4.2 Leading National Market Shares (%) for IVD, 2015
Figure 4.3 Leading National Market Shares (%) for IVD, 2021
Figure 4.4 US IVD Market Forecast ($bn), 2009-2021
Figure 4.5 Japanese IVD Market Forecast ($bn), 2009-2021
Figure 4.6 US and Japanese IVD Market Forecasts ($bn), 2009-2021
Figure 4.7 Top 5 EU IVD Market Forecasts ($bn), 2009-2021
Figure 4.8 Indian and Chinese IVD Market Forecasts ($bn), 2009-2021
Figure 4.9 IVD Market Forecast ($bn) for the Rest of the World, 2009-2021
Figure 4.10 Leading National Markets for IVD: Revenue Forecasts ($bn), 2009-2021
Figure 4.11 World IVD Market: Regional Market Shares (%), 2010
Figure 5.1 World Market Shares (%) for Major Therapy Areas for IVD Tests, 2010
Figure 5.2 Diabetes IVD Market Shares (%), 2010
Figure 5.3 Oncology IVD Market Shares (%), 2010
Figure 5.4 Infectious Immunology IVD Market Shares (%), 2010
Figure 5.5 US Infectious Immunology IVD Market Shares by Disease (%), 2010
Figure 5.6 HIV IVD Market Shares by Application (%), 2010
Figure 5.7 TB Diagnostics Market Shares (%), 2010
Figure 5.8 Cardiovascular Diagnostics Market Shares (%), 2010
Figure 5.9 Cardiac IVD Market by Test Type (%), 2010
Figure 6.1 Market Shares (%) of Leading Companies for IVD, 2010
Figure 6.2 Quest Diagnostics Revenue Shares (%) by Sector, 2009
Figure 6.3 LabCorp Diagnostics Revenue Shares (%), 2009
Figure 7.1 Average Response Rates for Various Diseases, 2011
Figure 7.2 Theranostics Market Forecast ($bn), 2009-2021
Figure 7.3 Diagnostics and Theranostics: Revenue Forecasts ($bn), 2009-2021
Companies Listed
23andMe
Abbott Laboratories
AmeriPath
Axis-Shield
Beckman Coulter
Becton, Dickinson and Company
BIOTEC Laboratories
bioTheranostics
Cellestis
Center for Disease Control and Prevention (CDC)
Clinical Data
Complete Genomics
Dade Behring
Dianon Systems
Duke University
Dynacare Laboratories
Enterix
EntroGen
Esoterix
European Diagnostic Manufacturers Association (EDMA)
European Medicines Evaluation Agency (EMEA)
Focus Diagnostics
Food and Drug Administration (US FDA)
Genetics & Public Policy Center
HemoCue
Hologic
Home Access Health
Laboratory Corporation of America
Litholink Corporation
Modern Health Systems
Monogram Biosciences
Myriad Genetics
National Genetics Institute
National Health Service (UK NHS)
Navigenics
OraSure Technologies
Oxford Immunotec
ParagonDx
Pathway Genomics
Pfizer
Prometheus
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Shenzhen Mindray Bio-Medical Electronics Co. (Mindray)
Siemens
State Food and Drug Administration (SFDA, China)
US LABS
Vermillion Diagnostics
ViroMed Laboratories
Walgreens
Warner-Chilcott
World Health Organization (WHO)
To order this report:
In Vitro Diagnostic Industry: In Vitro Diagnostics: World Market Outlook 2011-2021 - Can this market achieve growth?
In Vitro Diagnostic Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article